title: Macrophage-specific transgenic expression of cholesteryl ester hydrolase attenuates hepatic lipid accumulation and also improves glucose tolerance in ob/ob mice.
abstract: Cellular cholesterol homeostasis is increasingly being recognized as an important determinant of the inflammatory status of macrophages, and a decrease in cellular cholesterol levels polarizes macrophages toward an anti-inflammatory or M2 phenotype. Cholesteryl ester hydrolase (CEH) catalyzes the hydrolysis of stored intracellular cholesteryl esters (CE) and thereby enhances free cholesterol efflux and reduces cellular CE content. We have reported earlier reduced atherosclerosis as well as lesion necrosis and improved insulin sensitivity (due to decreased adipose tissue inflammation) in macrophage-specific CEH transgenic (CEHTg) mice in the LDLR(-/-) background. In the present study, we examined the effects of reduced intracellular accumulation of CE in CEHTg macrophages in an established diabetic mouse model, namely the leptin-deficient ob/ob mouse. Macrophage-specific transgenic expression of CEH improved glucose tolerance in ob/ob-CEHTg mice significantly compared with ob/ob nontransgenic littermates, but with no apparent change in macrophage infiltration into the adipose tissue. However, there was a significant decrease in hepatic lipid accumulation in ob/ob-CEHTg mice. Consistently, decreased [(14)C]acetate incorporation into total lipids and triglycerides was noted in precision-cut liver slices from ob/ob-CEHTg mice. In the primary hepatocyte-macrophage coculture system, macrophages from CEHTg mice significantly reduced the incorporation of [(14)C]acetate into triglycerides in hepatocytes, indicating a direct effect of macrophages on hepatocyte triglyceride biosynthesis. Kupffer cells isolated from ob/ob-CEHTg mice were polarized toward an anti-inflammatory M2 (Ly6C(lo)) phenotype. Taken together, these studies demonstrate that transgenic overexpression of CEH in macrophages polarizes hepatic macrophages (Kupffer cells) to an anti-inflammatory M2 phenotype that attenuates hepatic lipid synthesis and accumulation.
authors.affiliation: Dept. of Internal Medicine, Div. of Pulmonary and Critical Care, VCU Medical Center, Richmond, VA 23298-0050, USA.
authors.forename: Jinghua
authors.initials: J
authors.lastname: Bie
authors.forename: Bin
authors.initials: B
authors.lastname: Zhao
authors.forename: Kathryn E
authors.initials: KE
authors.lastname: Marqueen
authors.forename: Jing
authors.initials: J
authors.lastname: Wang
authors.forename: Barbara
authors.initials: B
authors.lastname: Szomju
authors.forename: Shobha
authors.initials: S
authors.lastname: Ghosh
mesh_terms: D000818:Animals; D001481:Basal Metabolism / Q000502:physiology; D050171:Dyslipidemias / Q000276:immunology / Q000378:metabolism; D018149:Glucose Intolerance / Q000276:immunology / Q000378:metabolism*; D006505:Hepatitis / Q000276:immunology / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology; D007728:Kupffer Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D008049:Lipase / Q000378:metabolism; D050356:Lipid Metabolism / Q000502:physiology*; D008264:Macrophages / Q000166:cytology / Q000201:enzymology* / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D008822:Mice, Transgenic; D009765:Obesity / Q000276:immunology / Q000378:metabolism; D010641:Phenotype; D061251:Primary Cell Culture; D011973:Receptors, LDL / Q000235:genetics / Q000378:metabolism; D002787:Sterol Esterase / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
chemical_list: D011973:Receptors, LDL; D002787:Sterol Esterase; D008049:Lipase